Luodan Suo1, Li Lu2, Qinghai Wang3, Fan Yang1, Xu Wang3, Xinghuo Pang1, Mona Marin4, Chengbin Wang5. 1. Beijing Center for Disease Control and Prevention, Beijing, China. 2. Beijing Center for Disease Control and Prevention, Beijing, China. Electronic address: lulibj@sina.com. 3. Xicheng District Center for Disease Control and Prevention, Beijing, China. 4. Centers for Disease Control and Prevention, Atlanta, GA, USA. 5. Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: cwang1@cdc.gov.
Abstract
BACKGROUND: Two-dose varicella vaccination has been available in Beijing since 2012 in the private sector. We investigated a varicella outbreak in a highly vaccinated elementary school population. METHODS: A cohort study was carried out and a varicella case was defined as an acute onset of generalized maculopapulovesicular rash without other apparent cause in a student attending the school from March 29 through May 17, 2015. Breakthrough varicella was defined as varicella >42days after the last vaccine dose among both 1- or 2-dose varicella vaccine recipients. Vaccination information was collected from immunization records; information on prior varicella and clinical presentations was collected by surveying students' parents. RESULTS: Of the 1056 students in the school, 1027 (97.3%) reported no history of varicella. Prior to the outbreak, 98.6% of students had received ≥1 dose of varicella vaccine, and most (63.2%) students received two doses. Twenty varicella cases were identified for an overall attack rate of 2.0%. Half of the cases occurred in the classroom of the index case-patient, a two-dose recipient who was not isolated after symptom onset. Breakthrough varicella accounted for 95% of cases (19/20) with attack rates of 14.3% (1/7), 1.6% (6/362) and 2.0% (13/649) among unvaccinated, one-dose, and two-dose students, respectively. Most case-patients (18/20, 90%) had <50 lesions. No difference in clinical presentations was found between one-dose and two-dose recipients with breakthrough varicella. CONCLUSION: Moderate two-dose varicella vaccine coverage was insufficient to prevent a varicella outbreak. Two-dose recipients with breakthrough varicella are contagious. High two-dose varicella vaccine coverage and timely isolation of cases may be needed for varicella outbreak prevention in the two-dose era. Published by Elsevier Ltd.
BACKGROUND: Two-dose varicella vaccination has been available in Beijing since 2012 in the private sector. We investigated a varicella outbreak in a highly vaccinated elementary school population. METHODS: A cohort study was carried out and a varicella case was defined as an acute onset of generalized maculopapulovesicular rash without other apparent cause in a student attending the school from March 29 through May 17, 2015. Breakthrough varicella was defined as varicella >42days after the last vaccine dose among both 1- or 2-dose varicella vaccine recipients. Vaccination information was collected from immunization records; information on prior varicella and clinical presentations was collected by surveying students' parents. RESULTS: Of the 1056 students in the school, 1027 (97.3%) reported no history of varicella. Prior to the outbreak, 98.6% of students had received ≥1 dose of varicella vaccine, and most (63.2%) students received two doses. Twenty varicella cases were identified for an overall attack rate of 2.0%. Half of the cases occurred in the classroom of the index case-patient, a two-dose recipient who was not isolated after symptom onset. Breakthrough varicella accounted for 95% of cases (19/20) with attack rates of 14.3% (1/7), 1.6% (6/362) and 2.0% (13/649) among unvaccinated, one-dose, and two-dose students, respectively. Most case-patients (18/20, 90%) had <50 lesions. No difference in clinical presentations was found between one-dose and two-dose recipients with breakthrough varicella. CONCLUSION: Moderate two-dose varicella vaccine coverage was insufficient to prevent a varicella outbreak. Two-dose recipients with breakthrough varicella are contagious. High two-dose varicella vaccine coverage and timely isolation of cases may be needed for varicella outbreak prevention in the two-dose era. Published by Elsevier Ltd.
Authors: Brian R Lee; Shelly L Feaver; Claudia A Miller; Craig W Hedberg; Kristen R Ehresmann Journal: J Infect Dis Date: 2004-06-29 Impact factor: 5.226
Authors: Carrie A Thomas; Thein Shwe; Dee Bixler; Maria del Rosario; Scott Grytdal; Chengbin Wang; Loretta E Haddy; Stephanie R Bialek Journal: Pediatr Infect Dis J Date: 2014-11 Impact factor: 2.129
Authors: Hua Zhu; Han Zhao; Rong Ou; Qing Zeng; Ling Hu; Hongfang Qiu; Manoj Sharma; Mengliang Ye Journal: Int J Environ Res Public Health Date: 2020-01-20 Impact factor: 3.390